Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Huangsheng Biotechnology is a Chinese medical technology company specializing in the research, development, and manufacturing of high-end medical consumables and bioactive materials. The company focuses on advanced wound care and surgical solutions, particularly absorbable hemostatic products and biological dressings. Their product portfolio includes absorbable gelatin sponges, oxidized regenerated cellulose, and other biomaterial-based products designed to control bleeding and promote tissue repair. Huangsheng Biotech operates with a strong emphasis on GMP-compliant manufacturing and serves both domestic and international healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Huangseng Biotechnology.